Imodium a-d and Ibu drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Imodium a-d (loperamide hydrochloride) and Ibu (ibuprofen). Common drug interactions include dyspnoea among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Imodium a-d and Ibu. It is created by eHealthMe based on reports of 277 people who take the same drugs from the FDA, and is updated regularly.
What is Imodium a-d?
Imodium a-d has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 8,944 Imodium a-d users. Check the latest studies of Imodium a-d.
What is Ibu?
Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
277 people who take Imodium a-d and Ibu together, and have interactions are studied.
What are the common drug interactions of Imodium a-d and Ibu, by gender? *
What are the common drug interactions of Imodium a-d and Ibu, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Imodium a-d and Ibu?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Imodium a-d (8,944 reports)
- Ibu (246,531 reports)
Browse all drug interactions of Imodium a-d and Ibu:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Imodium a-d:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Imodium a-d and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibu and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on loperamide hydrochloride and ibuprofen (the active ingredients of Imodium a-d and Ibu, respectively), and Imodium a-d and Ibu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pegasys and Cellulitis Aggravated for Women aged 50-59 - now
- Iron Deficiency Anaemia and drugs of ingredients of pancrelipase (amylase;lipase;protease) - a second ago
- Could Zantac cause Red Cell Distribution Width Increased? - a second ago
- Could Baclofen cause Cystitis Aggravated? - 2 seconds ago
- Gemzar and Jaundice - Yellow Skin for Women aged 40-49 - 8 seconds ago
- Gemzar and Yellow Skin And Eyes for Women aged 40-49 - 8 seconds ago
- Gemzar and Skin - Yellow for Women aged 40-49 - 9 seconds ago
- Gemzar and Jaundice for Women aged 40-49 - 9 seconds ago
- Gemzar and Icterus for Women aged 40-49 - 9 seconds ago
- Gemzar and Eyes - Yellow for Women aged 40-49 - 10 seconds ago